EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study

Teresa Gantes Padrão, Diana Pessoa, Joana Alves Luís, Diogo Alpuim Costa, Mário Fontes E Sousa, Ídilia Pina, Susana Palma de Sousa, Débora Cardoso, Sandra Bento, Joana Simões, Ana Ferreira, Renato Cunha und 4 weitere

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2025.09.013 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Teresa Gantes Padrão und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital da Luz Lisboa, Lisbon, Portugal. Electronic address: teresa.gantes.padrao@fundacaochampalimaud.pt. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Biomarkers, Tumor, Clinical Decision-Making. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasm Recurrence, LocalBiomarkers, TumorClinical Decision-MakingHumansFemaleRetrospective StudiesPortugalMiddle AgedErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneChemotherapy, AdjuvantAgedAdultPrognosisGene Expression ProfilingFollow-Up Studies

Stichwörter der Autor:innen

Adjuvant chemotherapyGenomic testingHormone receptor-positiveOncotype DXReal world

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneERBB2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Hospital da Luz Lisboa, Lisbon, Portugal. Electronic address: teresa.gantes.padrao@fundacaochampalimaud.pt.
  • Department of Medical Oncology, Instituto Português de Oncologia Lisboa, Lisbon, Portugal.
  • Department of Medical Oncology, Hospital Lusíadas Lisboa, Lisbon, Portugal.
  • Department of Medical Oncology, Hospital CUF Lisboa, Lisbon, Portugal.
  • Department of Medical Oncology, ULS do Arco Ribeirinho, Barreiro, Portugal.
  • Department of Medical Oncology, Hospital CUF Porto, Porto, Portugal.

Zitieren

APA

Padrão, T. G., Pessoa, D., Luís, J. A., Costa, D. A., Fontes E Sousa, M., Pina, Í., de Sousa, S. P., Cardoso, D., Bento, S., Simões, J., Ferreira, A., Cunha, R., Martins-Branco, D., Domingues, T. D., Passos-Coelho, J. L., & Portuguese 21-Gene Recurrence Score Assay National Study (2026). The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.09.013

Vancouver

Padrão TG, Pessoa D, Luís JA, Costa DA, Fontes E Sousa M, Pina Í, et al. The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.09.013

BibTeX
@article{Padro2026,
  author = {Padrão, Teresa Gantes and Pessoa, Diana and Luís, Joana Alves and Costa, Diogo Alpuim and Fontes E Sousa, Mário and Pina, Ídilia and de Sousa, Susana Palma and Cardoso, Débora and Bento, Sandra and Simões, Joana and Ferreira, Ana and Cunha, Renato and Martins-Branco, Diogo and Domingues, Tiago Dias and Passos-Coelho, José Luís and Portuguese 21-Gene Recurrence Score Assay National Study, Portuguese 21-Gene Recurrence Score Assay National Study},
  title = {The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2025.09.013}
}
Kostenlos starten →